サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：眼部インプラントの世界市場-2022-2029
市場調査レポート
商品コード
1169021

眼部インプラントの世界市場-2022-2029

Global Ocular Implant Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 200 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
眼部インプラントの世界市場-2022-2029
出版日: 2022年12月08日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

眼部インプラントの世界市場規模は、予測期間（2022-2029年）にCAGR6.8％で成長すると予測されています。

眼部インプラントは、外科手術によって恒久的に眼窩内に埋め込む医療機器です。このデバイスは、眼球に挿入後、長時間にわたって薬剤を送達するために使用されます。

市場力学

眼部インプラントの世界市場を牽引する主な要因は、緑内障、加齢黄斑変性（AMD）、白内障などの眼科疾患の発生率増加による眼部インプラントの需要増加、技術の進歩、新製品の上市などです。

意識向上への取り組みや、技術的に進歩した新しい眼部インプラントの台頭は、市場の成長を促進すると予想されます。

眼部インプラント市場は、技術の進歩の高まり、老年人口の増加、研究開発投資の急増、緑内障、白内障、AMDなどの眼科疾患の増加、新興国市場の医療インフラの改善とともに最新技術を用いた新規製品の改善によって牽引されています。

眼部インプラントは、薬物の送達や美容の目的で使用されます。これらのインプラントの採用は増加傾向にあり、政府の取り組みや資金の増加につながっています。これらの資金は、眼用レンズ、角膜用インプラント、緑内障用インプラントなどの眼部インプラント製品の生産に役立てられます。これらのアプリケーションの市場は、これらの呼吸器系疾患の患者数の増加により世界的に拡大しています。さらに、主要企業による技術的に高度な製品の提供も、市場の成長に重要な役割を果たすと予想されます。

様々な新規製品の発売、調査研究、これらの眼部インプラントに関する啓発活動の高まりは、市場の成長に寄与しています。例えば、2022年8月、インプラントレンズおよびデリバリーシステムの設計・提供会社であるSTAAR Surgical Company社は、乱視および近視矯正用に開発されたFDA承認の視力矯正用レンズ、EVO Visianという最新のインプラントコラメレンズについての認知度を高めるために、俳優兼歌手のJoe Jonas氏と新たに提携したことを発表しています。

眼部インプラントの承認に関連する製品リコールや厳しい規制は、市場の成長を妨げると予想されます。

眼部インプラントの承認に関する厳しい規則や規制は、眼部インプラント市場の成長を阻害する主な要因となっています。様々な要件を満たす必要があるため、これらのインプラントの総コストが上昇することになります。

市場のリコールもまた、市場の成長を抑制する主要な要因です。漏出や合併症により、いくつかのリコールが行われています。例えば、2022年10月、ロシュは製造に関連する問題により、同社のインプラントSusvimoをリコールしました。Susvimoは、湿性加齢黄斑変性症の人の眼にラニビズマブを送達する承認済みのインプラントです。送達デバイスの隔壁またはシールに製造上の問題があり、薬が漏れるのを防ぐことができないです。

COVID-19の影響分析

パンデミックは、世界の財務的な期待、オペレーション、危機対応戦略にマイナスの影響を及ぼしています。COVID-19の発生はヘルスケア産業に深刻な影響を及ぼしています。眼部インプラント市場は、COVIDのために莫大な損失を経験しました。主要メーカーは様々な研究・臨床試験を開始しました。様々なイニシアチブ、製品の発売、コラボレーション、合併が世界中で起こっており、市場の成長を後押ししています。例えば、2020年7月、インプラントレンズとデリバリーシステムの設計・提供会社であるSTAAR Surgical Companyは、老眼矯正用の斬新で革新的なインプラントコラメレンズ、EVO Viva/EVO Visian ICLがCEマークを取得したと発表しました。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場影響要因
    • 促進要因
      • 眼部インプラントの認知度向上のための取り組みの増加
      • 技術的進歩の高まり
    • 抑制要因
      • 眼部インプラントに関連する製品リコール
    • ビジネスチャンス
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • プライシング分析
  • 規制分析

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、または将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的取り組み
  • まとめ

第7章 製品タイプ別

  • 眼内レンズ
    • 単焦点眼内レンズ
    • 多焦点眼内レンズ
    • アコモデーション眼内レンズ
    • トーリック眼内レンズ
  • 緑内障用インプラント
  • 角膜インプラント
  • 眼部プロテーゼ
  • 眼窩用インプラント
  • その他

第8章 材料別

  • 疎水性アクリル
  • シリコーン
  • ポリメチルメタクリレート（PMMA）

第9章 用途別

  • ドラッグデリバリー
  • 緑内障手術
  • 加齢黄斑変性症
  • 眼科手術
  • 美容目的
  • その他

第10章 エンドユーザー別

  • 病院
  • 外来手術センター
  • 眼科専門クリニック
  • その他

第11章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第12章 競合情勢

  • 主な展開と戦略
  • 企業シェア分析
  • 製品ベンチマーク
  • 注目の主要企業リスト

第13章 企業プロファイル

  • Novartis AG
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Pfizer Inc.
  • Johnson & Johnson Services, Inc.
  • STAAR Surgical
  • Bausch & Lomb Incorporated.
  • Carl Zeiss
  • Ophtec BV
  • MORCHER GmbH
  • Genentech, Inc.
  • AbbVie Inc.

第14章 眼部インプラントの世界市場-DataM

目次
Product Code: DMMD1200

Market Overview

The global ocular implant market size was valued at US$ XX million in 2022 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 6.8% during the forecast period (2022-2029).

The ocular implant is a medical device that is surgically embedded inside the socket of the eye permanently. This device is used for delivering drugs after insertion into the eye for an extended time.

Market Dynamics

The major factors driving the global ocular implant market are the rising demand for ocular implants owing to increasing incidences of ophthalmic disorders such as glaucoma, age-related macular degeneration (AMD) and cataract, technological advancements and novel product launches.

The increasing awareness initiatives and rising novel technologically advanced ocular implants are expected to drive the market's growth.

The ocular implant market is driven by rising advancements in technology, an increase in the geriatric population, a surge in research and development investments, an increasing number of ophthalmic disorders such as glaucoma, cataract, AMD and improvements in novel products using the latest technology along with improvements in medical infrastructure in emerging markets.

The ocular implant is used for delivering drugs and aesthetic purposes. The adoption of these implants is increasing, leading to rising government initiatives and funds. These funds will help produce ocular implant products such as ocular lenses, corneal implants or glaucoma implants. The market for these applications is increasing worldwide due to the enhanced number of these respiratory disorders. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Various novel product launches, research studies, and rising awareness initiatives about these ocular implants contribute to the market's growth. For instance, in August 2022, STAAR Surgical Company, a designer and provider of implantable lenses and delivery systems, announced its new partnership with Joe Jonas, an actor and singer, to create awareness of its latest implantable Collamer lenses, EVO Visian, an FDA-approved lens for vision correction developed for astigmatism and myopia correction.

Product recalls and stringent regulations associated with the approval of ocular implants are expected to hamper the market's growth.

Strict rules and regulations for the approval of ocular implants is the major factor hindering the growth of the ocular implant market. Various requirements must be fulfilled, leading to an increase in the overall cost of these implants.

Market recalls are also a leading factor restraining the growth of the market. Several recalls are taking place due to leakage or complications. For instance, in October 2022, Roche recalled its implant Susvimo due to a manufacturing-related issue. Susvimo is an approved implant that delivers ranibizumab into the eye of people with wet age-related macular degeneration. The septum or seal of the delivery device has some manufacturing issues and cannot keep the medicine from leaking out.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The ocular implant market has experienced huge losses due to COVID. Key manufacturers have started various research and clinical trials. Various initiatives, product launches, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in July 2020, STAAR Surgical Company, a designer and provider of implantable lenses and delivery systems, announced its novel, innovative implantable Collamer lens, EVO Viva/ EVO Visian ICL, for presbyopia correction, received CE Mark.

Segment Analysis

The Intraocular lenses segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The intraocular lenses segment is the highest market holder in the global ocular implant market. The global ocular implant market is segmented based on product type as intraocular lenses, glaucoma implants, corneal implants, ocular prostheses, orbital implants and more. The intraocular lenses segment is the largest market shareholder due to its inherent advantages over other implants, increasing technological advancements and novel product launches.

Intraocular lenses are artificial lenses implanted into the eye for myopia or cataract treatment purposes. It replaces the natural lens of the eye removed during the surgery and restores distant or near vision. These lenses are of various types: accommodating, mono-focal, multifocal, and toric. One of the leading causes of blindness is cataracts which can be treated with the help of these implants through surgery.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, in September 2022, Johnson and Johnson Vision, part of Johnson and Johnson Medtech and an eye health company, introduced their novel intraocular lens powered by InteliLight technology and TECNIS symphony OptiBlue intraocular lens for correcting presbyopia. This lens with depth of focus joins the hybrid lens, TECNIS synergy intraocular lens, for spectacle independence in the InteliLight portfolio. This corrects presbyopia in more patients. These deliver low-light performance and superior contrast in this intraocular lens category.

Geographical Analysis

North America holds the largest market share in the global ocular implant market.

North America dominates the global ocular implant market primarily due to its large population, excellent medical infrastructure, and high-income levels. The market is expected to grow at a relatively moderate pace during the forecast period due to healthcare expenditure in the US. The market's significant size is attributed to the high medical expenditure.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of ocular implant applications in several ophthalmic conditions, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the ocular implant market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in Aug 2020, Johnson & Johnson Vision, a company focusing on eye health, announced that its TECNIS Eyhance and TECNIS synergy intraocular lenses for cataract treatment got approved by Health Canada and will be available in the Canadian market.

Competitive Landscape

The ocular implant market is highly competitive with local and global companies' presence. Novartis Inc., Pfizer Inc., Johnson & Johnson Services, Inc., STAAR Surgical, Bausch & Lomb Incorporated., Carl Zeiss, Ophtec BV, MORCHER GmbH, Genentech, Inc., AbbVie Inc. and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in July 2022, Bausch + Lomb Corporation, an eye health company and Sanoculis, an ophthalmic device company, announced their strategic agreements developed to focus on glaucoma's unmet needs.

Novartis AG

Overview: Novartis is engaged in discovering, developing, manufacturing, and selling a wide range of pharmaceutical and generic medicines. The company has two operating divisions globally: Innovative medicines and Sandoz for biosimilars and generic pharmaceuticals.

Product Portfolio:

Clareon intraocular lens: This has an advanced, disposable and pre-loaded delivery system optic material. It can be implanted with a delivery system that is unique and automated.

Key Development: In June 2022, Novartis announced its acquisition of Kedalion Therapeutics along with its innovative AcuStream technology, a device that can provide accurate delivery with precise dosing of ophthalmic medications. This acquisition will expand the ophthalmic portfolio of Novartis.

The global ocular implant market report would provide access to approx.: 45+market data table, 40+figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing awareness initiatives for these ocular implants
      • 4.1.1.2. Rising technological advancements
    • 4.1.2. Restraints:
      • 4.1.2.1. Product recalls associated with ocular implant
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis
  • 5.4 Regulatory Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. Intraocular Lenses *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
    • 7.2.3. Monofocal IOLs
    • 7.2.4. MultifocalIOLs
    • 7.2.5. Accommodating IOLs
    • 7.2.6. Toric IOLs
  • 7.3. Glaucoma Implants
  • 7.4. Corneal Implants
  • 7.5. Ocular Prosthesis
  • 7.6. Orbital Implants
  • 7.7. Others

8. By Material

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 8.1.2. Market Attractiveness Index, By Material
  • 8.2. Hydrophobic Acrylic *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Silicone
  • 8.4. Polymethylmethacrylate (PMMA)

9. By Application

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 9.1.2. Market Attractiveness Index, By Application
  • 9.2. Drug Delivery *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Glaucoma Surgery
  • 9.4. Age-related Macular Degeneration
  • 9.5. Oculoplasty
  • 9.6. Aesthetic Purpose
  • 9.7. Others

10. By End-User

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.1.2. Market Attractiveness Index, By End-User
  • 10.2. Hospitals *
    • 10.2.1. Introduction
    • 10.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 10.3. Ambulatory Surgical Centers
  • 10.4. Eye Specialty Clinics
  • 10.5. Others

11. By Region

  • 11.1. Introduction
    • 11.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 11.1.2. Market Attractiveness Index, By Region
  • 11.2. North America
    • 11.2.1. Introduction
    • 11.2.2. Key Region-Specific Dynamics
    • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.2.7.1. U.S.
      • 11.2.7.2. Canada
      • 11.2.7.3. Mexico
  • 11.3. Europe
    • 11.3.1. Introduction
    • 11.3.2. Key Region-Specific Dynamics
    • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.3.7.1. Germany
      • 11.3.7.2. U.K.
      • 11.3.7.3. France
      • 11.3.7.4. Italy
      • 11.3.7.5. Spain
      • 11.3.7.6. Rest of Europe
  • 11.4. South America
    • 11.4.1. Introduction
    • 11.4.2. Key Region-Specific Dynamics
    • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.4.7.1. Brazil
      • 11.4.7.2. Argentina
      • 11.4.7.3. Rest of South America
  • 11.5. Asia Pacific
    • 11.5.1. Introduction
    • 11.5.2. Key Region-Specific Dynamics
    • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 11.5.7.1. China
      • 11.5.7.2. India
      • 11.5.7.3. Japan
      • 11.5.7.4. Australia
      • 11.5.7.5. Rest of Asia Pacific
  • 11.6. Middle East and Africa
    • 11.6.1. Introduction
    • 11.6.2. Key Region-Specific Dynamics
    • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Material
    • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

12. Competitive Landscape

  • 12.1. Key Developments and Strategies
  • 12.2. Company Share Analysis
  • 12.3. Products Benchmarking
  • 12.4. List of Key Companies to Watch

13. Company Profiles

  • 13.1. Novartis AG *
    • 13.1.1. Company Overview
    • 13.1.2. Product Portfolio and Description
    • 13.1.3. Key Highlights
    • 13.1.4. Financial Overview
  • 13.2. Pfizer Inc.
  • 13.3. Johnson & Johnson Services, Inc.
  • 13.4. STAAR Surgical
  • 13.5. Bausch & Lomb Incorporated.
  • 13.6. Carl Zeiss
  • 13.7. Ophtec BV
  • 13.8. MORCHER GmbH
  • 13.9. Genentech, Inc.
  • 13.10. AbbVie Inc.

LIST NOT EXHAUSTIVE

14. Global Ocular Implant Market - DataM

  • 14.1. Appendix
  • 14.2. About Us and Application
  • 14.3. Contact Us